Delhi govt. strict on Addictive drugs

  • News
  • September 2, 2016
New Delhi – To stop abuse of prescription drugs, the Delhi government’s drug control department will keep a tab on the sale and purchase of addictive medicines in pharmacies across the city. Earlier this month, the department issued a circular to all medicine shops asking them to keep a limited stock of such drugs, maintain records and sell habit-forming medicines only on prescription. “It is important to prevent people from abusing pharmaceutical drugs since once they do so they might graduate to abuse synthetic and illegal drugs. Patients get addicted to certain drugs that are available over the counter after using them over a period of time. In most cases, people take such medicines without consulting a doctor,” said Dr. Mrinalini Darswal, drug controller. New guidelines state chemists must stock habit-forming drugs only on a “need-basis” and send a monthly report to the government. “They (shops) should limit the stock of such drugs for maximum one month. Any unexplained stock will attract stringent punishment,” the circular read. “These measures may cause inconvenience to medicine shop owners. But they are important for public health. It is a welcome decision,” said Sandeep Nangia, president of Retail Distributors Chemists Association (RDCA). The chemists have been asked to inform the drug control department if there is a “sudden surge or unexplained hike in demand of such habit-forming drugs” at their wholesale or retail stores. They have been requested to report any person selling these drugs illegally or without prescription in their area. “The department will concentrate on border areas, resettlement colonies and areas near North Campus, South Campus and JNU (Jawaharlal Nehru University) and others where students live in large numbers. We have seen pharmaceutical drugs are mostly abused by truckers, poor and homeless and students,” said an official. In the last one year, licences of 14 shops in northwest Delhi’s Mahendar Park and west Delhi’s Khayala had been cancelled. The department has stopped issuing new licences in areas known for drug abuse. The order has named seven commonly abused drugs which the department will keep a tab on – Buprenorphine (used to treat opiod addiction), Pentazocaine and Tramadol (opium-based pain-killer), Avil (used to treat allergies), Codein-based cough syrups like Corex and Phensidyl, Alprazolam (used to treat anxiety disorder) and Diazepam (a tranquilising, muscle-relaxant).

Related Posts

‘A Knight in Shining Armor’ packed a punch in FOGSI for Gender Equality

New Delhi: There was no fog in sight; FOGSI was shining as never before, thanks to the leadership of its outgoing president Dr Hrishikesh Pai. The over 40, 000 strong…

  • News
  • December 16, 2023
  • 16 views
Women are on Trajectory to make Presence Felt in Healthcare India

New Delhi: It could be advantage patients in times to come as women as workforce are increasing in healthcare domain of India. It is given that women power blended with…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

Ramdev, Balkrishna Acharya Ready For ‘Public Apology’; Supreme Court Next Hearing On April 23

Organovo’s Drug Significantly Reduces Liver Fat In NASH Study

Organovo’s Drug Significantly Reduces Liver Fat In NASH Study

Significant Decline In Pharma Deals In Q1

Significant Decline In Pharma Deals In Q1